EATG » CROI 2019: Gilead announces data on Descovy for PrEP

CROI 2019: Gilead announces data on Descovy for PrEP

Gilead announces data demonstrating non-inferiority of once-daily Descovy® vs. once-daily Truvada® for prevention of HIV infection

– DISCOVER trial meets primary and secondary endpoints and will support supplemental regulatory filing for Descovy for pre-exposure prophylaxis (PrEP) –

Read the full press release here.

 

SEE ALSO:


 

Source:
Gilead Sciences, Inc.
News categories: PrEP, CROI 2019